The Relevance of Asymptomatic Endometriosis

Hormone research · 2008 · vol. 32(1) , pp. 115–116 · doi:10.1159/000181323 · W2090548366
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This placebo-controlled study found that gestrinone treatment more effectively reduces spontaneous improvement in asymptomatic endometriosis than placebo.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The recent ability to diagnose asymptomatic endometriosis has produced dilemmas, particularly with respect to the need for treatment. The first placebo-controlled study of drug treatment in asymptomatic endometriosis shows that although spontaneous improvement occurs, it is more likely after treatment with gestrinone.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Gestrinone Norpregnatrienes Endometriosis Endometriosis Female Gestrinone Humans Norpregnatrienes

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (5)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:15.954262+00:00
License: CC0 · commercial use OK